CHAIRMAN OF MEDICAL EDUCATION – DR SAMER ELLAHHAM, MD, CPHQ, EFQM, FACMQ, FACP, FACC, FAHA, FCCP
Dr. Ellahham is currently a Senior Cardiovascular Consultant and Director of Accreditation in the Quality and Safety Institute in Cleveland Clinic Abu Dhabi. He is the middle east regional chair, Patient Safety Movement Foundation, ISQua Expert, AHA Hospital Accreditation Science Committee, Member, European Society of Cardiology Heart Failure Writing Group, Member, ex-Middle East Representative of the JCI Standards Subcommittee and American College of Cardiology Accreditation Foundation Board, Member. Dr. Ellahham is a recognized innovative leader in quality, safety, patient experience, artificial intelligence, blockchain, telehealth, clinical cardiology, and the use of robust performance improvement in improving healthcare delivery. He serves on several US and international prestigious committees and advisory bodies.
Current Educational roles
• Editor of The Journal of Cardiology & Cardiovascular Therapy
• Associate editor of the American Journal of Medical Quality.
• Editorial board member of:
• Journal of Thoracic Disease and Cardiothoracic Surgery.
• Developments in Clinical & Medical Pathology (DCMP).
• The Joint Commission Journal on Quality and Patient Safety.
• Telehealth and Medicine Today (TMT).
• Blockchain journal (BHTY).
• Medical Science.
• Open Journal of Cardiatic Research.
• UPI Journal of Pharmaceutical.
• Medical and Health Sciences (UPI-JPMHS, Open Access Research in Anatomy,
• Gerontology & Geriatrics studies and Open Access Journal of Clinical Trials
• Hypertension Today Journal and Focus on Hypertension Journal
• Journal of Heart Health
• Cardiovascular Pharmacology
• Scientific Research, and Community,
• Journal of Surgery and Surgical Procedures
• EC Cardiology
• Journal of Cardiovascular and Pulmonary Medicine
• Canadian Journal of Biomedical Research.
Dr. Ellahham is American Board Certified in Internal Medicine, Cardiovascular Disease, Vascular Medicine, and American Board of Medical Quality. He was recently recertified in 2017 by the American Board of Cardiology (ABIM). He is a Certified Professional in Healthcare Quality (CPHQ) by The National Association for Healthcare Quality (NAHQ), certified in Medical Quality (CMQ) by The American Board of Medical Quality (ABMQ), certified as EFQM Model assessor and Lead Trainer in TeamSTEPPS. Dr. Ellahham is a fellow of the American College of Cardiology, American Heart Association, American College of Chest Physicians, American College of Physicians, and American College of Medical Quality. He is a fellow of the American College of Cardiology and a key member of Heart Failure and Transplant, Adult Congenital and Pediatric Cardiology, Cardio-oncology, Innovation, Quality, and Peripheral Vascular Disease Sections. He is a Distinguished Fellow of the New Westminster College in British Columbia, Canada, and Advisory Board Member, the University of Wollongong in Dubai.
Recently leadership roles.
He led the First AHA GWTG Heart Failure Initiative outside the US and was the recipient of the AHA GWTG Award in Wash. DC. He is the champion of the AHA GWTG in the region. Dr. Ellahham has served as Chief Quality Officer for SKMC from 2009 till 2017. In his role, he has led the development of a quality and program that has been successful and visible and has been recognized internationally by several awards. As Chief Quality Officer and Global Healthcare Leader, he had a focus on ensuring that the implementation of these best practices leads to breakthrough improvements in clinical quality, patient safety, patient experience, and risk management.
Dr. Ellahham was the Executive SKMC sponsor of the American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP®) the leading US validated, risk-adjusted, outcomes-based program to measure and improve the quality of surgical care. SKMC is the first multispecialty ACS NSQIP center outside the US. He led the publication of, first in the region, annual SKMC outcome books since 2011and he is a strong believer in transparency in health care and external reporting. He was the leader of the First Pilot International Robust Process Improvement (RPI) project by the Joint Commission Center for Transforming Healthcare and several other similar successful performance improvement projects at SKMC. Dr. Ellahham was the Middle East Representative of the JCI Standards Subcommittee and Member on the Editorial Advisory Board of the Joint Commission Journal on Quality and Patient Safety. He was a reviewer of HCAC Cardiac Quality and Safety Standards. Dr. Ellahham has been a champion and leader of the use of Lean, Six Sigma and Change Management to improve healthcare quality and has numerous publications in this area. He is Lean Six Sigma Master Black Belt Certified. He is an American Society of Quality (ASQ) trainer in Lean and Six Sigma both green and black belt. He is ISQua Expert.
He received several research awards including the DuPont Pharmaceuticals Research Award, ACCP 58th Annual Scientific Assembly, Young Investigator Award; the Alfred Soffer Research Award, ACCP 58th Annual Scientific Assembly, Finalist; the First Young Investigator Award 12th, Annual Meeting of the Mediterranean Association of Cardiology and Cardiac Surgery, American Heart Association Get with the Guidelines Award, SKMC Infection Prevention Award in 2011 and 2012, Sheikh Khalifa Excellence Award in 2014, Quality Leadership Award from the World Quality Congress and Awards, Business Leadership Excellence Award from World Leadership Congress in 2015, one the nominees for Safe Care magazine Person of the Year in the United States, Dubai Quality Award in 2015 and Sheikh Khalifa Excellence Golden Award in 2015.
Dr. Ellahham received his undergraduate degree in biology and his M.D. from The American University of Beirut, Beirut, Lebanon. Dr. Ellahham finished his internal medicine residency at Georgetown University Hospital - Washington Hospital Center and his fellowship in Cardiology at the Virginia Commonwealth University Health System in the USA. Dr. Ellahham worked in Washington DC at Georgetown University Hospital - Washington Hospital Center and in several clinical and leadership positions before moving to UAE in 2008.
CHIEF EXECUTIVE OFFICER – NATHAN NAGEL
Mr Nathan Nagel is a serial medical entrepreneur with 21 years’ experience in business and 14 years in board leadership positions. In addition to being CEO of MEMP he has a portfolio of current board advisory positions in biotechnology and AI healthtech companies. His executive experience includes CEO at Gamlen Tableting Ltd, Board Adviser at the Mayfair Biohub Ltd, Interim Managing Director of the US liver disease CRO Sanyal Bio LLC, interim CEO of the neuroscience biotechnology company Neuro-Bio Ltd and CEO of the market research company Oncology Pharma Ltd. In parallel to leading Oncology Pharma Ltd Nathan was managing partner of LifeScience Ventures Ltd, a UK consulting company. Prior to leading companies Nathan worked for Bayer Diagnostics and Takeda Pharmaceuticals, where he started his career. Nathan lives in London, Dubai and extensively travels across the Middle East.
DIRECTOR OF AI AND INFORMATICS – PROFESSOR GRAHAM BALL, MA, PhD
Prof Graham Ball is Professor of Bioinformatics at Nottingham Trent University. Prof Ball specialises in the application of innovative artificial intelligence and machine learning methods to the analysis of complex data in the biological, environmental and biomedical domains. For over 30 years, Prof Ball has been a lead figure in the development and validation of bioinformatics algorithms, using Artificial Neural Networks and Machine learning, in health, environmental and biomedical data. He has focussed on applying these approaches to public data repositories leveraging actionable and translational features from the data. He has 190+ journal papers and 7 patents in this area. After a PhD (UN funded) and a Post Doc modelling environmental interactions with Artificial Intelligence and Machine Learning at Nottingham Trent University, in 2000 he shifted the focus of his analysis to biomedical data searching for patterns associated with disease.
DIRECTOR OF ONCOLOGY – DR NICK PLOWMAN, MA, MD, FRCP, FRCR
Globally respected oncologist and experienced physician to government leaders and royalty. Senior Clinical Oncologist to St Bartholomew’s Hospital and The Hospital for Sick Children Great Ormond Street. Dr P N Plowman qualified from Cambridge University with a double first in medical sciences and natural sciences and has been a consultant oncologist at St Bartholomew’s Hospital and the Hospital for Sick Children in London for thirty years. His research work has led to the introduction of aromatase inhibitors into breast cancer management and glucocorticoids into advanced prostate cancer management, thereby making significant advantages and changes in best standard care to these two common important cancers. Dr Plowman has forwarded the practice of modern radiotherapy (for example, in children) and will shortly be part of a team introducing Linac-based proton beam radiotherapy into clinical practice
DIRECTOR OF SURGERY – DR MATTEO VIGO, MD and Elite Specialist Plastic Surgeon
Dr. Vigo is currently working in Amwaj Polyclinic as Medical Director and Specialist Plastic Surgeon. He is also working in the Healthbay Clinic. He has recently increased his interest in the field of regenerative medicine with the use of stem cells. His scope of work now it well built around the whole spectrum of breast procedures, where he applies latest technology and techniques combined with his past experience learning from the top surgeons in the field. Dr. Vigo has been the main trainer for all Europe and the Middle East for Celution and Pure Graft systems by Cytori, lecturing in different important congresses around the world. In 2012 he started working in Dubai as a Chief of Surgery and Chief Medical Officer at American Academy of Cosmetic Surgery Hospital, until March 2017. His qualifications include Specialization in Plastic and Reconstructive Surgery – University of Verona (Italy), Fellowship in Plastic and Reconstructive Surgery- Department of Plastic Surgery and burns, Centre – Ospedale Maggior Borgo Trento – Verona and a degree in Medicine and Surgery – University Vita-Salute san Raffele Milano (Italy)
DIRECTOR OF TRAINING – PROFESSOR SAMAR AHMED, MSc, MD, PhD, JMHPE
Professor Samar Ahmed, MSc, MD, JMHPE is the Director at Ain Shams Middle East North Africa FAIMER Regional Institute for Health Professions Education. Chair of the Centre of excellence in Forensic psychiatric research Ain Shams University. Professor in the department of forensic medicine and toxicology Ain Shams University. Advisory Board Member Towards Unity for Health www.TUFH.org Director of the FAIMER Fellowship in Health professions Education ASU-MENA-FRI. Member of the EU funding task force ministry of Higher Education and scientific research and project office in the ShERACA Plus EU funding project. Member of the steering committee for faculty strategic planning ASU. Editor of the Journal of Forensic Psychology. Editor of the Journal of Forensic Medicine and Legal Affairs. Certified UNESCO Trainer Ain Shams University Faculty of Medicine. Director Quality assurance unit ASU-FOM. Global commercial adviser to Universities and medical schools.
DR ASA BAPAT – DIRECTOR OF REGENERATIVE MEDICINE AND REGULATORY AFFAIRS
Dr Asawari Bapat (Aasa) is the Director of Quality and Regulatory Affairs, at Infohealth FZE, based in Dubai and US; a Global Consultant for medical labs and cellular therapies for excellence in quality, regulatory compliance, accreditations and certifications; International Ambassador, AABB (American Association of Blood Banks) for cellular therapies in the Middle East; Advisor to the Parents Guide to Cord Blood foundation; Ex-chair for laying down Cord Blood banking regulations in India associated with DCGI, ICMR India. Dr Bapat qualifications include M.B.B.S, D.P.B (CPS, Clinical Pathology), P.G.D.H.H.M (Hospital and Healthcare Management).
ALISON MAGNALL – LEAD NURSE AND CLINICAL ADVISER
Alison is a sophisticated, well respected and effective healthcare professional proven in achieving best outcomes in healthcare and academic settings and working with MEMP since January 2019. She is a practicing Nurse in Oxford as well as providing consultancy for a number of projects. Her main strengths are in communication, teaching and presenting, teamworking, project and quality management, regulation and accreditation, research, strategic planning, business partnerships, and change management in the UK and Middle East. In addition to her clinical qualifications Alison has a Bachelor’s Degree in English Language and Literature and a Master’s Degree in Humanities from Oxford University.
DR JULIAN STONE
Dr Julian Stone is a serial investor and technology entrepreneur and serves on the board of several medical technology businesses. He has 30 years’ commercial experience with 20 years in medical technology, software, hardware, big data, and analytics. Dr Stone has led teams in both SME’S and multibillion-dollar corporates and has invested and mentored a wide variety of medical technology businesses. He holds a DBA and MBA.
DR DONALD GIBB
Dr Gibb is a serial investor and medical entrepreneur and sits on multiple medical company boards. Dr Gibb is a member of the Royal College of Obstetricians and Gynaecologists and was awarded the Gold Medal in 1980. He was made a member of the Royal College of Physicians in 1981 and a fellow of the Royal College of Obstetricians and Gynaecologists in 1991. In 1990 he was awarded an MD from Edinburgh University for research work on labour and delivery carried out in Singapore.